SCHEMBL497717

SCHEMBL497717

N[C@@H](CCCO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL59755 1.00
SCHEMBL31036022 1.00
Methane SCHEMBL28231705 0.97 GSR (0.60)
Water SCHEMBL28187164 0.97 GSR (0.60)
SCHEMBL128663 0.92 GSR (0.67)
SCHEMBL197363 0.92 GSR (0.67)
SCHEMBL2684333 0.92 GSR (0.67)
Ornithine SCHEMBL9403237 0.91 GSR (0.72)
SCHEMBL31370110 0.90 GSR (0.64)
Hydrochloric Acid SCHEMBL21837618 0.90 GSR (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 559 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12084476-B2 Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors Universität Duisburg-Essen (DE) 2024-09-10 US claimed
EP-3625243-B1 TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS UNIV DUISBURG ESSEN (DE) 2023-10-18 EP claimed
US-20220002348-A1 TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS Universität Duisburg-Essen (DE) 2022-01-06 US claimed
US-11149067-B2 Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors Universität Duisburg-Essen (DE) 2021-10-19 US claimed
CN-112020930-B Method for inducing rice to improve salt tolerance 江苏沿海地区农业科学研究所 2021-10-08 CN claimed
CN-112020930-A Method for inducing rice to improve salt tolerance 江苏沿海地区农业科学研究所 2020-12-04 CN claimed
EP-3019624-B1 BIOMARKERS OF AUTISM SPECTRUM DISORDER STEMINA BIOMARKER DISCOVERY INC (US) 2020-09-16 EP claimed
EP-3625243-A1 TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS Universität Duisburg-Essen (DE) 2020-03-25 EP claimed
US-20200071360-A1 TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS Universität Duisburg-Essen (DE) 2020-03-05 US claimed
US-20190072569-A1 BIOMARKERS OF AUTISM SPECTRUM DISORDER STEMINA BIOMARKER DISCOVERY, INC. 2019-03-07 US claimed
US-8501683-B2 Cycloundecadepsipeptide compounds and use of said compounds as a medicament DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2013-08-06 US claimed
WO-2011141891-A1 USE OF CYCLOUNDECADEPSIPEPTIDE COMPOUNDS DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2011-11-17 WO claimed
US-20110212057-A1 CYCLOUNDECADEPSIPEPTIDE COMPOUNDS AND USE OF SAID COMPOUNDS AS A MEDICAMENT DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2011-09-01 US claimed
EP-2355837-A1 CYCLOUNDECADEPSIPEPTIDE COMPOUNDS AND USE OF SAID COMPOUNDS AS A MEDICAMENT DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2011-08-17 EP claimed
US-20110014669-A1 Production of 1,4 Butanediol in a Microorganism MICROBIA, INC. 2011-01-20 US claimed
WO-2010085731-A2 PRODUCTION OF 1,4 BUTANEDIOL IN A MICROORGANISM MICROBIA, INC. (US) 2010-07-29 WO claimed
WO-2010052559-A1 CYCLOUNDECADEPSIPEPTIDE COMPOUNDS AND USE OF SAID COMPOUNDS AS A MEDICAMENT DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2010-05-14 WO claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed